Matrix Metalloproteinases and ADAMs in Stroke

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2019 Jun 6

PMID 31165904

Citations 30

Authors

Joan Montaner

Laura Ramiro

Alba Simats

Mar Hernandez-Guillamon

Pilar Delgado

Alejandro Bustamante

Anna Rosell

Affiliations

Soon will be listed here.

Abstract

Stroke is a leading cause of death and disability worldwide. However, after years of in-depth research, the pathophysiology of stroke is still not fully understood. Increasing evidence shows that matrix metalloproteinases (MMPs) and "a disintegrin and metalloproteinase" (ADAMs) participate in the neuro-inflammatory cascade that is triggered during stroke but also in recovery phases of the disease. This review covers the involvement of these proteins in brain injury following cerebral ischemia which has been widely studied in recent years, with efforts to modulate this group of proteins in neuroprotective therapies, together with their implication in neurorepair mechanisms. Moreover, the review also discusses the role of these proteins in specific forms of neurovascular disease, such as small vessel diseases and intracerebral hemorrhage. Finally, the potential use of MMPs and ADAMs as guiding biomarkers of brain injury and repair for decision-making in cases of stroke is also discussed.

Citing Articles

The role of IL-17 in the pathogenesis and treatment of glioblastoma-an update on the state of the art and future perspectives.

Laszczych D, Czernicka A, Gostomczyk K, Szylberg L, Borowczak J Med Oncol. 2024; 41(8):187.

PMID: 38918274 PMC: 11199243. DOI: 10.1007/s12032-024-02434-1.

New Insights on Mechanisms and Therapeutic Targets of Cerebral Edema.

Shang P, Zheng R, Wu K, Yuan C, Pan S Curr Neuropharmacol. 2024; 22(14):2330-2352.

PMID: 38808718 PMC: 11451312. DOI: 10.2174/1570159X22666240528160237.

In vitro dose-dependent effects of matrix metalloproteinases on ECM hydrogel biodegradation.

Didwischus N, Guduru A, Badylak S, Modo M Acta Biomater. 2023; 174():104-115.

PMID: 38081445 PMC: 10775082. DOI: 10.1016/j.actbio.2023.12.003.

Vitamin A, D, E, and K as Matrix Metalloproteinase-2/9 Regulators That Affect Expression and Enzymatic Activity.

Vo H, Nguyen Y, Kim N, Lee H Int J Mol Sci. 2023; 24(23).

PMID: 38069361 PMC: 10707015. DOI: 10.3390/ijms242317038.

The Role and Therapeutic Implications of Inflammation in the Pathogenesis of Brain Arteriovenous Malformations.

Ricciardelli A, Robledo A, Fish J, Kan P, Harris T, Wythe J Biomedicines. 2023; 11(11).

PMID: 38001877 PMC: 10669898. DOI: 10.3390/biomedicines11112876.

References

Auerbach I, Vinters H . Effects of anoxia and hypoxia on amyloid precursor protein processing in cerebral microvascular smooth muscle cells. J Neuropathol Exp Neurol. 2006; 65(6):610-20. DOI: 10.1097/00005072-200606000-00009. View

Tejima E, Guo S, Murata Y, Arai K, Lok J, van Leyen K . Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1. J Neurotrauma. 2009; 26(11):1935-41. PMC: 2822804. DOI: 10.1089/neu.2009.0959. View

Hurtado O, Cardenas A, Lizasoain I, Bosca L, Leza J, Lorenzo P . Up-regulation of TNF-alpha convertase (TACE/ADAM17) after oxygen-glucose deprivation in rat forebrain slices. Neuropharmacology. 2001; 40(8):1094-102. DOI: 10.1016/s0028-3908(01)00035-1. View

Chen Y, Ho W, Lee Y, Chen H, Chen C . Polymorphisms in the Promoters of the MMP-2 and TIMP-2 Genes Are Associated with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population. PLoS One. 2015; 10(11):e0142482. PMC: 4638341. DOI: 10.1371/journal.pone.0142482. View

Koenen R, Pruessmeyer J, Soehnlein O, Fraemohs L, Zernecke A, Schwarz N . Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood. 2009; 113(19):4799-809. DOI: 10.1182/blood-2008-04-152330. View

Tanaka H, Takai S, Jin D, Furubayashi K, Inoue N, Kajimoto Y . Inhibition of matrix metalloproteinase-9 activity by trandolapril after middle cerebral artery occlusion in rats. Hypertens Res. 2007; 30(5):469-75. DOI: 10.1291/hypres.30.469. View

Kim S, Singh M, Huang J, Prestigiacomo C, Winfree C, Solomon R . Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery. 1997; 41(3):642-66; discussion 646-7. DOI: 10.1097/00006123-199709000-00027. View

Koistinaho M, Malm T, Kettunen M, Goldsteins G, Starckx S, Kauppinen R . Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice. J Cereb Blood Flow Metab. 2005; 25(4):460-7. DOI: 10.1038/sj.jcbfm.9600040. View

Peeters S, Engelen L, Buijs J, Jorsal A, Parving H, Tarnow L . Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study. Cardiovasc Diabetol. 2017; 16(1):55. PMC: 5405549. DOI: 10.1186/s12933-017-0539-1. View

10.

Park K, Rosell A, Foerch C, Xing C, Kim W, Lee S . Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats. Stroke. 2009; 40(8):2836-42. PMC: 3712850. DOI: 10.1161/STROKEAHA.109.554824. View

11.

Gidday J, Gasche Y, Copin J, Shah A, Perez R, Shapiro S . Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol. 2005; 289(2):H558-68. DOI: 10.1152/ajpheart.01275.2004. View

12.

Sharma R, Macy S, Richardson K, Lokhnygina Y, Laskowitz D . A blood-based biomarker panel to detect acute stroke. J Stroke Cerebrovasc Dis. 2013; 23(5):910-8. DOI: 10.1016/j.jstrokecerebrovasdis.2013.07.034. View

13.

Lo E, Wang X, Cuzner M . Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res. 2002; 69(1):1-9. DOI: 10.1002/jnr.10270. View

14.

Hernandez-Guillamon M, Martinez-Saez E, Delgado P, Domingues-Montanari S, Boada C, Penalba A . MMP-2/MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke. Brain Pathol. 2011; 22(2):133-41. PMC: 8029059. DOI: 10.1111/j.1750-3639.2011.00512.x. View

15.

Peeters W, Moll F, Vink A, van der Spek P, de Kleijn D, de Vries J . Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome. Eur Heart J. 2011; 32(18):2314-25. DOI: 10.1093/eurheartj/ehq517. View

16.

Lapchak P, Chapman D, Zivin J . Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke. 2000; 31(12):3034-40. DOI: 10.1161/01.str.31.12.3034. View

17.

Wang Y, Herrera A, Li Y, Belani K, Walcheck B . Regulation of mature ADAM17 by redox agents for L-selectin shedding. J Immunol. 2009; 182(4):2449-57. PMC: 2653275. DOI: 10.4049/jimmunol.0802770. View

18.

Ho W, Chen C, Lee Y, Chang K, Chen H, Chen S . Association of MMP-9 Haplotypes and TIMP-1 Polymorphism with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population. PLoS One. 2015; 10(5):e0125397. PMC: 4416754. DOI: 10.1371/journal.pone.0125397. View

19.

Lemarchant S, Dunghana H, Pomeshchik Y, Leinonen H, Kolosowska N, Korhonen P . Anti-inflammatory effects of ADAMTS-4 in a mouse model of ischemic stroke. Glia. 2016; 64(9):1492-507. DOI: 10.1002/glia.23017. View

20.

Lee J, Yin K, Hsin I, Chen S, Fryer J, Holtzman D . Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy. Ann Neurol. 2003; 54(3):379-82. DOI: 10.1002/ana.10671. View